Senator Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Senator Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-450,000	Closed	-$98.5M	–	46
2019 Q4	$98.5M	Sell	450,000 -50,000	-10%	-$10.1M	2.7%	15
2019 Q3	$84.7M	Buy	500,000 +50,000	+11%	+$8.85M	2.13%	21
2019 Q2	$82.5M	Buy	+450,000	New	+$78.7M	1.52%	31
2019 Q1	–	Sell	-400,000	Closed	-$66.3M	–	46
2018 Q4	$66.3M	Sell	400,000 -175,000	-30%	-$30.3M	1.85%	22
2018 Q3	$111M	Sell	575,000 -145,000	-20%	-$25.8M	1.43%	29
2018 Q2	$122M	Buy	720,000 +320,483	+80%	+$49.7M	1.22%	31
2018 Q1	$65.1M	Buy	+399,517	New	+$65.3M	0.77%	33
2016 Q3	–	Sell	-395,000	Closed	-$34M	–	71
2016 Q2	$34M	Sell	395,000 -605,000	-61%	-$52.3M	0.54%	43
2016 Q1	$79.5M	Buy	+1,000,000	New	+$90.5M	1.05%	37

Other funds holding VRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Senator Investment Group's VRTX Position: Q1 2020 in Review

Senator Investment Group sold out of Vertex Pharmaceuticals (VRTX) in Q1 2020, closing a stake of 450,000 shares — an estimated $98.5M sold.

Senator Investment Group first reported a position in VRTX in Q1 2016 and held it in 9 quarters. The position peaked at $122M in Q2 2018. 855 funds tracked by Wall St. Rank hold VRTX as of Q1 2020.

Senator Investment Group reported no remaining Vertex Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Senator Investment Group sold 450,000 Vertex Pharmaceuticals shares in Q1 2020, an estimated $98.5M.
Senator Investment Group first reported a position in Vertex Pharmaceuticals in Q1 2016 and held it in 9 quarters.
Senator Investment Group's Vertex Pharmaceuticals position peaked at $122M in Q2 2018.
855 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2020.

Based on Senator Investment Group's 13F filing for Q1 2020, filed 15 May 2020.